These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33377498)

  • 1. Transparency Is Not Enough: How Can We Improve the Management of Financial Conflicts of Interest Between Pharma and Healthcare Sectors?
    Ozaki A; Murayama A; Saito H; Sawano T; Harada K; Senoo Y; Yamamoto K; Tanimoto T
    Clin Pharmacol Ther; 2021 Aug; 110(2):289-291. PubMed ID: 33377498
    [No Abstract]   [Full Text] [Related]  

  • 2. Conflicts of interest with the health industry.
    Dubois MY
    Pain Med; 2006; 7(5):463-5. PubMed ID: 17014609
    [No Abstract]   [Full Text] [Related]  

  • 3. Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression.
    Cosgrove L; Krimsky S; Wheeler EE; Peters SM; Brodt M; Shaughnessy AF
    Account Res; 2017; 24(2):99-115. PubMed ID: 27901595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New guidelines for the disclosure of academic-industry financial ties and modeling professionalism during medical education.
    Reddi A
    JAMA Pediatr; 2013 Dec; 167(12):1091-2. PubMed ID: 24081013
    [No Abstract]   [Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy for relationships with companies: background and rationale.
    American Society of Clinical Oncology
    J Clin Oncol; 2013 Jun; 31(16):2037-42. PubMed ID: 23610121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conflict questions. Insurance execs on healthcare boards prompts worry.
    Benko LB
    Mod Healthc; 2005 May; 35(22):10. PubMed ID: 15940804
    [No Abstract]   [Full Text] [Related]  

  • 7. Conflicts of interest in pain medicine: Practice patterns and relationships with industry.
    Schofferman J; Banja J
    Pain; 2008 Oct; 139(3):494-497. PubMed ID: 18814969
    [No Abstract]   [Full Text] [Related]  

  • 8. Letting the sunshine in on doctor-pharma relationships.
    Jack A
    BMJ; 2011 Oct; 343():d6459. PubMed ID: 21990283
    [No Abstract]   [Full Text] [Related]  

  • 9. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology.
    Prendergast MM; Abramovits W; Boguniewicz M; Lebwohl M; Tokar M; Tong KB
    J Invest Dermatol; 2004 Sep; 123(3):452-4. PubMed ID: 15304081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declaration of conflicts of interest in scientific publications.
    Möller HJ
    World J Biol Psychiatry; 2009; 10(1):2-5. PubMed ID: 19140091
    [No Abstract]   [Full Text] [Related]  

  • 11. American Society of Clinical Oncology: Policy for relationships with companies.
    American Society of Clinical Oncology
    J Clin Oncol; 2013 Jun; 31(16):2043-6. PubMed ID: 23610118
    [No Abstract]   [Full Text] [Related]  

  • 12. High Reliability Organizations--Medication Safety.
    Yip L; Farmer B
    J Med Toxicol; 2015 Jun; 11(2):257-61. PubMed ID: 25812532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conflicts of interest and clinical drug trials -- impact of the pharmaceutical industry and the impingement on the integrity of medical science].
    Ludwig WD; Hildebrandt M; Schott G
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(3):149-54. PubMed ID: 19554889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transparency of industry payments needed in clinical practice guidelines.
    Vassar M; Bibens M; Wayant C
    BMJ Evid Based Med; 2019 Feb; 24(1):8-9. PubMed ID: 30042209
    [No Abstract]   [Full Text] [Related]  

  • 15. Financial Conflicts of Interest Among Authors of Urology Clinical Practice Guidelines.
    Carlisle A; Bowers A; Wayant C; Meyer C; Vassar M
    Eur Urol; 2018 Sep; 74(3):348-354. PubMed ID: 29747945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disclosure of conflicts of interest in biomedical publications.
    Miller DR
    Can J Anaesth; 2008 May; 55(5):265-7, 267-9. PubMed ID: 18451113
    [No Abstract]   [Full Text] [Related]  

  • 17. [Scientific societies and their economic relationship with the companies. Situation in Spain].
    Ruano-Ravina A
    Med Clin (Barc); 2012 May; 138(14):614-6. PubMed ID: 22440141
    [No Abstract]   [Full Text] [Related]  

  • 18. Disclosing conflict of interest does not mitigate healthcare bias and harm: It is time to sever industry ties.
    James JE
    Eur J Clin Invest; 2020 Dec; 50(12):e13344. PubMed ID: 32654125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.
    Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
    PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National transparency assessment of Kuwait's pharmaceutical sector.
    Badawi DA; Alkhamis Y; Qaddoumi M; Behbehani K
    Health Policy; 2015 Sep; 119(9):1275-83. PubMed ID: 26229022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.